gene

TRAIL

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TRAIL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

113Connections
0Hypotheses
1Analyses
50Outgoing
41Incoming
0Experiments
1Debates

Summary

Comprehensive information about TRAIL (TNF-Related Apoptosis-Inducing Ligand), a member of the TNF superfamily involved in neuronal apoptosis, neuroinflammation, and neurodegenerative diseases

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolTNFSF10
AliasesTNF-Related Apoptosis-Inducing Ligand
Chromosome3q26
Functionis a type II transmembrane protein belonging to the TNF superfamily.
Primary Expressionbrain cells of Alzheimer's disease patients at significantly elevated levels compared to age-matched controls
Molecular Weight32.5 kDa (monomer), ~97.5 kDa (homotrimer)
Amino Acids281 aa
PathwaysAkt, Apoptosis, ER stress, Glycolysis, Mapk
UniProt IDP50591
GeneCardsTNFSF10
Human Protein AtlasTNFSF10
Associated DiseasesALS, traumatic brain injury, TUMOR
InteractionsActin, AKT1, AMPK, AND, APOPTOSIS, App
KG Connections113 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING
🔮 Predicted Structure: TRAIL — AlphaFold P50591 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (7)

Knowledge base pages for this entity

Canonical Page

TRAIL (TNF-Related Apoptosis-Inducing Ligand) Protein

protein · 1206 words

TRAIL Gene (TNFSF10)

gene · 2784 words

TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical Alzheimer's Disease

clinical · 1966 words

TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Disease (NCT05463731)

clinical · 1479 words

Donanemab TRAILBLAZER-ALZ 2 Trial

clinical · 1023 words

Donanemab TRAILBLAZER Open-Label Extension

clinical · 984 words

Pathway Diagram

graph TD
    TRAIL["TRAIL"]
    ALS{"ALS"}
    TRAIL -->|"activates"| ALS
    Inflammation{"Inflammation"}
    TRAIL -->|"activates"| Inflammation
    Cancer{"Cancer"}
    TRAIL -->|"activates"| Cancer
    Tumor{"Tumor"}
    TRAIL -->|"inhibits"| Tumor
    TRAIL -->|"inhibits"| Cancer
    Als{"Als"}
    TRAIL -->|"activates"| Als
    Ms{"Ms"}
    TRAIL -->|"activates"| Ms
    TRAIL -->|"activates"| Tumor
    CANCER["CANCER"]
    TRAIL -->|"inhibits"| CANCER
    Immune_Response(["Immune Response"])
    TRAIL -->|"inhibits"| Immune_Response
    INFLAMMATION["INFLAMMATION"]
    TRAIL -->|"activates"| INFLAMMATION
    RIPK1["RIPK1"]
    TRAIL -->|"activates"| RIPK1
    RIPK1 -->|"activates"| TRAIL
    JUN["JUN"]
    JUN -->|"activates"| TRAIL
    TERRA["TERRA"]
    TERRA -->|"activates"| TRAIL
    AMPK["AMPK"]
    AMPK -->|"activates"| TRAIL
    INFLAMMATION -->|"activates"| TRAIL
    CANCER -->|"activates"| TRAIL
    IFNG["IFNG"]
    IFNG -->|"inhibits"| TRAIL
    GENES["GENES"]
    GENES -->|"inhibits"| TRAIL
    MHC_I["MHC-I"]
    MHC_I -->|"causes"| TRAIL
    AND["AND"]
    AND -->|"activates"| TRAIL
    TRAF6["TRAF6"]
    TRAF6 -->|"activates"| TRAIL
    JNK["JNK"]
    JNK -->|"activates"| TRAIL
    style TRAIL fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (72)

TargetRelationTypeStr
Alsactivatesdisease0.65
Msactivatesdisease0.65
Tumoractivatesdisease0.65
Alstherapeutic_targetdisease0.65
Cancertherapeutic_targetdisease0.65

Incoming (41)

SourceRelationTypeStr
RIPK1activatesgene0.60
JUNactivatesgene0.60
GENESinhibitsgene0.60
MHC-Icausesgene0.60
PD1causesgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

What amyloid threshold level is required for optimal clinical benefit in early A

neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.933

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

While the study demonstrates dose-response relationships between amyloid levels

closed · Rounds: 4 · Score: 0.76 · 2026-04-16

Related Research

Hypotheses and analyses mentioning TRAIL in their description or question text

No additional research found